OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:28455
Who is this for?
Show terms as
8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pancreatic beta cell agenesis with neonatal diabetes mellitus is a very rare condition present from birth in which the pancreas fails to develop the special cells — called beta cells — that normally make insulin. Insulin is a hormone the body needs to control blood sugar levels. Without working beta cells, the body cannot produce insulin at all, leading to extremely high blood sugar (glucose) levels from the first days or weeks of life. This condition is sometimes referred to as neonatal diabetes due to beta cell agenesis or congenital beta cell aplasia. Babies born with this condition typically show signs of diabetes very early — often within the first few weeks of life. Symptoms include high blood sugar, weight loss, dehydration, and failure to grow and gain weight normally. Because the pancreas also plays a role in digestion, some children may have problems absorbing nutrients from food. Treatment focuses on replacing insulin through injections or an insulin pump, which is lifesaving. Unlike the more common type 1 diabetes, this condition is caused by a genetic problem that prevents beta cells from forming in the first place, rather than an immune system attack. With careful management, children can survive and grow, but they require lifelong insulin therapy and close medical monitoring. This condition is listed as 'obsolete' in some medical databases, meaning it may now be classified under more specific genetic diagnoses.

Key symptoms:

Very high blood sugar levels from birth or early infancyFailure to gain weight or grow normally (failure to thrive)DehydrationExcessive urinationExcessive thirst or poor feedingLethargy or unusual sleepinessRapid breathingDigestive problems due to poor pancreatic functionLow birth weight in some cases

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus community →

No specialists are currently listed for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

Iressa

AstraZeneca Pharmaceuticals LP

Iressa Patient Support (AZ&Me)

Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitusForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.

Start the conversation →

Latest news about OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus

No recent news articles for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific gene mutation is causing my child's condition, and what does that mean for their long-term health?,Should my child use an insulin pump or continuous glucose monitor, and how do we get access to these devices?,Does my child's pancreas also have trouble making digestive enzymes, and do they need enzyme supplements?,What are the signs of diabetic ketoacidosis, and exactly what should I do if I think my child is having one?,Are there any clinical trials or research studies my child might be eligible for?,What should the school nurse and teachers know about managing my child's condition safely at school?,Should other family members be tested for the gene mutation that caused this condition?

Common questions about OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus

What is OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus?

Pancreatic beta cell agenesis with neonatal diabetes mellitus is a very rare condition present from birth in which the pancreas fails to develop the special cells — called beta cells — that normally make insulin. Insulin is a hormone the body needs to control blood sugar levels. Without working beta cells, the body cannot produce insulin at all, leading to extremely high blood sugar (glucose) levels from the first days or weeks of life. This condition is sometimes referred to as neonatal diabetes due to beta cell agenesis or congenital beta cell aplasia. Babies born with this condition typica

How is OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus inherited?

OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus typically begin?

Typical onset of OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus?

1 patient support program are currently tracked on UniteRare for OBSOLETE: Pancreatic beta cell agenesis with neonatal diabetes mellitus. See the treatments and support programs sections for copay assistance, eligibility, and contact details.